Hanson & Doremus Investment Management’s Organon & Co OGN Stock Holding History

Hanson & Doremus Investment Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,636	Closed	-$26K	–	517
2025 Q2	$26K	Buy	+2,636	New	+$27.2K	﹤0.01%	375
2024 Q3	–	Sell	-124	Closed	-$3K	–	439
2024 Q2	$3K	Hold	124	–	–	﹤0.01%	443
2024 Q1	$2K	Hold	124	–	–	﹤0.01%	456
2023 Q4	$2K	Hold	124	–	–	﹤0.01%	447
2023 Q3	$2K	Hold	124	–	–	﹤0.01%	415
2023 Q2	$3K	Hold	124	–	–	﹤0.01%	433
2023 Q1	$3K	Hold	124	–	–	﹤0.01%	446
2022 Q4	$3K	Sell	124 -120	-49%	-$3.07K	﹤0.01%	494
2022 Q3	$6K	Hold	244	–	–	﹤0.01%	468
2022 Q2	$8K	Hold	244	–	–	﹤0.01%	466
2022 Q1	$9K	Hold	244	–	–	﹤0.01%	457
2021 Q4	$7K	Hold	244	–	–	﹤0.01%	438
2021 Q3	$8K	Buy	+244	New	+$7.81K	﹤0.01%	412

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Hanson & Doremus Investment Management's OGN Position: Q3 2025 in Review

Hanson & Doremus Investment Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 2,636 shares — an estimated $26K sold.

Hanson & Doremus Investment Management first reported a position in OGN in Q3 2021 and held it in 13 quarters. The position peaked at $26K in Q2 2025. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

Hanson & Doremus Investment Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
Hanson & Doremus Investment Management sold 2,636 Organon & Co shares in Q3 2025, an estimated $26K.
Hanson & Doremus Investment Management first reported a position in Organon & Co in Q3 2021 and held it in 13 quarters.
Hanson & Doremus Investment Management's Organon & Co position peaked at $26K in Q2 2025.
670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Hanson & Doremus Investment Management's 13F filing for Q3 2025, filed 15 Oct 2025.